During the past decade, Landesklinikum Wiener Neustadt conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landesklinikum Wiener Neustadt" #1 sponsor was "Celgene" with 5 trials, followed by "Austrian Breast & Colorectal Cancer Study Group" with 4 trials sponsored, "Medical University of Graz" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landesklinikum Wiener Neustadt" #1 collaborator was "Medical University of Vienna" with 3 trials as a collaborator, "Elisabethinen Hospital" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Landesklinikum Wiener Neustadt" are "Breast Cancer" (3 trials), "AV Block" (1 trials), "Advanced Cancer" (1 trials), "Antimetabolites, Antineoplastic" (1 trials) and "Brain Injuries" (1 trials). Many other conditions were trialed in "Landesklinikum Wiener Neustadt" in a lesser frequency.

Most popular intervention types in "Landesklinikum Wiener Neustadt" are "Drug" (16 trials), "Device" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Docetaxel" (2 trials), "Gemcitabine" (2 trials), "5-Fluoruracil, Cisplatinum" (1 trials) and "Abraxane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landesklinikum Wiener Neustadt" are 20 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Landesklinikum Wiener Neustadt". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Landesklinikum Wiener Neustadt, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Landesklinikum Wiener Neustadt, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".